Synonyms: AMG 139 | AMG-139 | MEDI2070
Compound class:
Antibody
Comment: Brazikumab (AMG 139, MEDI2070) is a fully human anti-IL23A monoclonal antibody in clinical development for autoimmune indications.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. BLAST peptide anaylsis reveals identical matches with peptides claimed in patent WO2011056600 [3]. |
Classification | |
Compound class | Antibody |
International Nonproprietary Names | |
INN number | INN |
10425 | brazikumab |
Synonyms |
AMG 139 | AMG-139 | MEDI2070 |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 664 |
Other databases | |
GtoPdb PubChem SID | 318164812 |
Search PubMed clinical trials | brazikumab |
Search PubMed titles | brazikumab |
Search PubMed titles/abstracts | brazikumab |